While Consumers Rush to Buy Cars, Companies Accelerate Collaborations, IPOs, and Acquisitions
————————Events and Perspectives————————
Picking up where we left off, we previously discussed how health product and pharmaceutical e-commerce platforms actively joined the fray during the “Double 11” shopping festival. After the frenzied 24 hours, how did each camp fare? Below, we reveal the Top 10 stores by sales volume:
Furthermore, data shows that goji berries were the most sought-after item.
What does this indicate?
“It was the best of times, it was the worst of times,” for after the spending spree, one still has to pinch their wallet.
At the same time that everyone was scrambling to “buy cars,” they were frantically forging partnerships, going public, and making acquisitions.
Join forces for collaboration.
Zhang Qiang Doctor Group’s Beijing Hernia Clinical Base Established at Shanfang Hospital.
On the 12th, the Hernia Clinical Base of Dr. Zhang Qiang’s Medical Group (Beijing) was established at Shanfang Hospital, simultaneously introducing an internationally leading new model of individualized, precision treatment for inguinal hernias to provide patients with higher-end, high-quality diagnostic and therapeutic services for hernia diseases. In addition, plans are being considered to establish the medical group’s male aesthetic surgery service base at Shanfang Hospital, with anti-aging and wellness as the key focuses of male aesthetic procedures.
At the conference, Zhang Qiang also revealed that, in accordance with international practice, physicians will receive 30%–70% of consultation and treatment fees as compensation, based on their seniority.
It has to be said that they really know how to take the pulse of the market.
In addition, the first Chinese-language international telemedicine project was also launched in Beijing.
Recently, the China-US Chinese Physician Telemedicine Collaboration Project, jointly launched by China-Japan Friendship Hospital and the American Chinese Physicians Network Hospital, was inaugurated in Beijing. As the world’s first Chinese-language international telemedicine initiative, the project will provide international telemedicine services to patients in both China and the United States. Chinese patients can schedule appointments with Chinese-American physicians in the U.S. simply by calling a toll-free consultation hotline.
As planned, the US Chinese Physicians Network Hospital and China-Japan Friendship Hospital will each establish teleconsultation rooms to create a reciprocal telemedicine platform. In China, patients can schedule remote consultations with US-based Chinese physicians by simply calling a toll-free number. Similarly, Chinese patients in the United States and Canada can contact the call center of the US Chinese Physicians Network Hospital by phone to book appointments with licensed practitioners in China for remote medical consultations. When Chinese patients are determined to require medical care following initial consultations, they can be referred to any of the more than 1,000 hospitals currently partnered with China-Japan Friendship Hospital for teleconsultations, while receiving remote guidance from US-based Chinese physicians. For complex cases requiring multidisciplinary consultation, the platform will invite additional renowned physicians worldwide to provide diagnostic and treatment recommendations.
Next up is China Mobile, which has also been making significant moves in recent days.
November 11,China Mobile and TEDA International Cardiovascular Hospital Sign Strategic Cooperation Agreement in Tianjin, Officially Launching a New Model of Collaboration Between Telecom Operators and Healthcare Institutions.Under the strategic agreement, China Mobile will partner with Taixin Hospital, leveraging the hospital as a clinical medical base, to jointly establish the “China Mobile–Taixin Hospital Mobile Health Application Experimental Platform” in the Binhai New Area of Tianjin. Through this platform, mobile health products will be developed based on clinical needs, professionally evaluated and incubated, piloted and medically validated within the hospital, and subsequently promoted nationwide across China.
On the same day, both parties also launched the “Ai Hu Xin” product, a personalized service solution that provides patients with closed-loop, dedicated cardiovascular care and health management. This solution enables continuous and comprehensive out-of-hospital “dual-heart” diagnosis and treatment for cardiovascular disease patients, thereby reducing readmission rates and medical costs while improving quality of life.
Unlike the aforementioned cross-"XX" initiatives, Shaanxi Province has achieved unified consensus within its orthopedic community.
Recently,The Orthopedic Medical Group, jointly established by 78 hospitals in Shaanxi Province and led by Xi’an Honghui Hospital, has been officially inaugurated.
The benefit is that, in the future, patients with general orthopedic conditions will no longer need to travel all the way to Xi’an; they can receive standardized treatment of the same quality at any of these 78 member hospitals.
Furthermore, a symposium on the new medical service system was held after the conference. Discussions focused on strengthening inter-hospital collaboration under the new medical system and improving the quality of orthopedic care and technical capabilities in primary-care hospitals.
"Going Public" for the Second Time.
Last week,China’s First Fully Online Diabetes Insurance Product—“Tui Tang Gu”—Officially Launched.
This is a health insurance product specifically designed for diabetes patients, jointly launched by the internet insurance service platform Da Te Bao, the traditional insurer China Taiping Insurance, and Munich Re of Germany. It provides coverage for four complications associated with diabetes: sequelae of stroke, end-stage renal disease, amputation, and blindness. Patients aged 30 to 65 are eligible to enroll, with renewal options available up to age 68. The annual premium starts at RMB 276, with a maximum sum insured of RMB 300,000. A lump-sum payment is made upon confirmation of diagnosis.
Starting November 12, users can view and purchase various service packages through the official websites, WeChat accounts, and mobile apps of Dataibao, as well as via the themed pages on the official apps of Zhangshang Tangyi (Pocket Sugar Doctor), Weitang (Micro Sugar), and Xuetang Gaoguan (Blood Glucose Executive). These offerings provide scenario-based services tailored for patients with diabetes. It has been disclosed that “Tuitanggu” will also sequentially partner with two major diabetes management platforms, Yuetang and Tang Hushi (Sugar Nurse). As the service content and management plans differ across these diabetes health management platforms, the pricing for purchasing “Tuitanggu” varies accordingly.
It is reported that this August, Taikang Life’s specialized health management subsidiary launched a diabetes insurance product called “Taikang Sweet Life Type A” in collaboration with Tang Hushi (Sugar Nurse). However, the product is no longer listed on Taikang Life’s official website.
Unlike the market debut of “Tui Tang Gu,” Wenzhou Kangning Hospital opted for a listing in Hong Kong.
November 11 news: Wenzhou Kangning Hospital has commenced its initial public offering in the Hong Kong market, issuing 17.6 million H shares at a price range of HK$32.1 to HK$38.7 per share, aiming to raise between HK$565 million and HK$681 million. The company is expected to be officially listed on the Hong Kong Stock Exchange on November 20.
Currently, the Group owns nine medical institutions, including five self-owned and self-operated specialized psychiatric hospitals and four medical institutions managed through management agreements. The first institution, Wenzhou Kangning Hospital, was established in 1996 and has since developed into the only private psychiatric hospital in China classified as a Grade A Tertiary (Class III, Grade A) facility.
The company’s disclosed financial data indicate that, based on 2014 revenue, Wenzhou Kangning Hospital ranked second in China’s psychiatric medical market with a market share of 0.99%, trailing only the Shanghai Mental Health Center at 1.90% and slightly surpassing Beijing Anding Hospital at 0.95%.
In an era where people were drinking melamine-contaminated milk, eating fried dough sticks cooked with gutter oil, and consuming salted eggs tainted with Sudan Red dye,
Go mad or become a demon—which do you choose?
Three-way merger and acquisition.
Fossil Group Acquires Misfit for $260 Million.
Fossil Group, a watch manufacturer, announced last week that it would acquire Misfit, the creator of various wearable devices as well as sleep-tracking and health-tracking platforms, for $260 million. Additionally, Sonny Vu, CEO of Misfit, will become the Chief Technology Officer of Fossil Group.
Through this acquisition, the Fossil Group can bring greater visibility to the brand. The Fossil Group’s announcement also stated that it would offer consumers a choice between traditional timepieces and fashionable connected accessories.
Winning Health Invests RMB 30 Million in Internet Healthcare Company.
Winning Health announced last night that the company plans to use RMB 30 million of its own funds to acquire a 90% equity stake in Shenzhen Yidian Tong Internet Technology Co., Ltd. Since its establishment, Yidian Tong has been dedicated to providing comprehensive digital hospital information system solutions.
Furthermore, on the same day, the Company entered into a Strategic Cooperation Framework Agreement with Zheshang Property Insurance Co., Ltd. With the aim of promoting the development of the health service industry and commercial health insurance, both parties leveraged their respective strengths, focusing on “medical healthcare cloud services + health insurance” as the key breakthrough area. Through resource integration, collaborative innovation, and joint exploration and development, they have reached a consensus on cooperation through friendly negotiations, laying a solid foundation for long-term collaboration on specific projects.
ECI Healthcare's Subsidiary Plans to Invest RMB 20 Million for a Stake in Zexin Software.
Sunwin Medical Announcement: The company’s controlled subsidiary, YiHui Technology, plans to invest RMB 20 million to acquire a stake in Zexin Software through a unilateral capital increase. Upon completion of the transaction, YiHui Technology will hold a 20% equity interest in Zexin Software.
Zexin Software is a modern healthcare information services company dedicated to providing comprehensive medical software solutions for healthcare institutions. It owns five innovative products with independent intellectual property rights: Electronic Medical Records (EMR), Hospital Infection Control Software, Hospital Integration Platform, Hospital Intelligent Analytics Platform, and Hospital Information System (HIS).
Medtronic and Sequoia Capital Establish Venture Capital Fund, Raising $60 Million in Initial Close.
Medtronic Announces Partnership with Sequoia Capital to Jointly Establish the Medtronic-Sequoia China Healthcare Technology Early-Stage Innovation Fund, Seeking Promising Startups in the Healthcare Technology Sector Across Global Markets with a Focus on China, and Providing Strategic Resources Including Financial Investment and a Suite of Value-Added Services. Suzhou BioBAY, renowned domestically for its incubation services for healthcare technology startups, will also join this fund as a limited partner and strategic collaborator. The initial closing of the Medtronic-Sequoia China Healthcare Technology Early-Stage Innovation Fund totals $60 million, primarily dedicated to investing in startups originating from local Chinese innovations whose products and business models possess global potential. It also focuses on introducing healthcare technologies and products developed by overseas innovative enterprises that meet the unique needs of the Chinese market, assisting them in achieving localization and commercialization in China.
In addition, Chen Penghui, Partner at Sequoia Capital China responsible for healthcare investments, will represent Sequoia on the Investment Committee of the Medtronic-Sequoia China Healthcare Technology Early Innovation Investment Fund.
Kangmei Pharmaceutical Partners with Bao'an District Government, Investing RMB 3 Billion to Bolster the Big Health Sector.
Recently, Kangmei Pharmaceutical disclosed an announcement that the company has signed a strategic cooperation framework agreement with the Shenzhen Bao'an District Government, planning to invest 3 billion yuan in the region to promote multiple projects related to general health.
The announcement stated that the cooperation between the two parties in Shenzhen in fields such as cultural exchange, innovative research, health and wellness, elderly care, and tumor rehabilitation would help the company leverage its advantages across the entire traditional Chinese medicine (TCM) industry chain to further accelerate the extension and implementation of its “Big Health + Big Platform + Big Data + Big Service” strategic framework in first-tier cities. It would also facilitate the company’s creation of a comprehensive online-offline integrated healthcare and pharmaceutical ecosystem for holistic health through the innovative integration of pharmaceuticals and medical services.
It is reported that Kangmei Pharmaceutical has been actively expanding its presence in the big health sector since the beginning of this year. In January, the company announced a RMB 1 billion investment to build the China-ASEAN Kangmei Yulin Traditional Chinese Medicine Industrial Park project. In February, it revealed a partnership with WeChat to establish a foothold in pharmaceutical e-commerce. In March, Kangmei became the first pilot unit for informatization in healthcare designated by the National Administration of Traditional Chinese Medicine and entered the mobile healthcare field. In May, it joined hands with Zhongheng Group to create an internet-based big health ecosystem.
Finally, Tim Cook’s statement, “Apple will develop medical devices, but not the Apple Watch,” propelled medical wearables into the spotlight.
He stated that using the Apple Watch for tests related to food and medication management would slow down Apple’s update cycles and hinder the pace of innovation. Reportedly, this marks the first time Apple has clarified that it will not develop the Apple Watch into a medical tracking device.
Will this model impact the company's new product launch? We will wait and see...
————————————Exclusive to VCBeat————————————
Smart Sensor Market: How Are Giants Like Apple, Samsung, and Google Strategizing?
A Review of Apple’s Strategic Layout in the Smart Sensor Sector
Day Surgery Isn’t All the Rage—Hospitals Without Beds Are Even More Impressive!
Interpretation of Trending English Terms in Digital Health: CBT
————————Healthcare Reform————————
Nanjing Establishes “Municipal Medical Administration Commission”; Health and Family Planning Commission to Cease Direct Management of Public Hospitals
The General Office of the Nanjing Municipal People’s Government issued the “Implementation Opinions on the Pilot Reform of the Management System of Urban Public Hospitals,” clarifying the separation between the government’s supervisory responsibilities in healthcare provision and the autonomous operational management rights of public hospitals. The “Nanjing Medical Administration Commission” was established, marking the transition of the Nanjing Municipal Health and Family Planning Commission from direct management of public hospitals to industry-wide oversight. The relevant pilot reform initiatives are scheduled to be completed by December this year.
According to the “Opinions,” the scope of reform is limited to public hospitals at the municipal and district levels. A Nanjing Municipal Government Public Hospital Management Committee will be established to fulfill the government’s responsibilities in operating hospitals. The committee will primarily be responsible for studying and deciding on major issues concerning same-level public hospitals, including their establishment and scale, development planning, implementation of major projects, fiscal investment, operational oversight, and performance evaluation. The Mayor of Nanjing will serve as the Director of the Municipal Medical Management Committee, and the Vice Mayor in charge will serve as its Deputy Director.
The Office of the Nanjing Medical Administration Committee is housed within the Nanjing Municipal Health and Family Planning Commission. The guidelines clarify that the Commission will shift its role from direct management of public hospitals to industry-wide oversight, strengthening its responsibilities in formulating and supervising policies, regulations, industry plans, and standards.
Jiangsu: Outpatient IV Infusions to Be Banned at Tier-2 Hospitals and Above Next Year
The Jiangsu Provincial Health and Family Planning Commission issued the “Notice on Further Strengthening the Clinical Application Management of Antibacterial Drugs,” which stipulated regulations for outpatient intravenous infusions. Effective July 1, 2016, all secondary-and-above-level hospitals in the province (excluding children’s hospitals) were to completely cease administering intravenous antibacterial drugs to outpatients; by the end of 2016, these hospitals (excluding children’s hospitals) were to completely cease all intravenous infusions for outpatients. In other words, prescribing infusion medications for outpatient care will no longer be permitted; patients requiring intravenous therapy must seek treatment through emergency services or hospitalization.
Furthermore, the notice states that medical institutions will prioritize the review of high-volume antibiotic users, including clinical departments such as Infectious Diseases, Surgery, Respiratory Medicine, and Critical Care Medicine, as well as cases involving Class I incision surgeries and interventional diagnostic and therapeutic procedures. The review results will serve as a critical basis for granting prescription privileges to departments and medical personnel, as well as for performance evaluations.
Physicians who issue more than three inappropriate antimicrobial prescriptions without valid justification shall be warned and have their prescribing privileges for antimicrobial agents restricted. If, after such restriction, they continue to issue inappropriate prescriptions without valid justification, their prescribing privileges for antimicrobial agents shall be revoked and may not be reinstated within six months.
Guangdong: Associate Chief Physicians at Public Hospitals Allowed to Open Private Clinics
Liao Xinbo, an inspector with the Guangdong Provincial Health and Family Planning Commission, stated that Guangdong Province has recently reissued guidelines on multi-site practice for physicians. The guidelines permit associate chief physicians in public hospitals to establish private clinics and operate physician studios under their own names. Meanwhile, general practitioners are encouraged to collaborate with hospitals in team-based models to foster new forms of productivity and production relations. In addition to promoting multi-site practice for physicians, pilot programs for nurses’ multi-site practice are also underway.
State Council: Promoting the Integration of Medical and Health Services with Elderly Care
On November 11, Premier Li Keqiang presided over an executive meeting of the State Council. The meeting pointed out that promoting the integration of medical and health services with elderly care is a people-centered initiative that deepens healthcare reform, addresses population aging, and enhances the well-being of hundreds of millions of families, while also driving substantial job creation. The meeting determined the following measures: First, facilitate the integration and coordination of medical and elderly care services. Medical institutions shall establish expedited appointment channels for elderly care facilities, and medical units established within elderly care facilities may serve as sites for hospital-based rehabilitation and nursing care. Support elderly care institutions in establishing geriatric, rehabilitation, traditional Chinese medicine (TCM) hospitals, and hospice care facilities in accordance with relevant regulations.
structures, etc. We will promote the integration of primary healthcare institutions with community and home-based elderly care services, providing contracted medical services to households with elderly members. Second, we encourage social forces to establish integrated medical and elderly care institutions, and support areas with abundant medical resources in transforming public hospitals into facilities for rehabilitation, geriatric nursing, and similar services. Third, we will strengthen support in areas such as financing and land use, expand government procurement of basic health and elderly care services, and innovate products such as long-term care insurance. The meeting decided to select at least one region in each province across China to carry out pilot demonstrations of integrated medical and elderly care.
New Standards Issued for Price Integrity Evaluation of Private Hospitals in Taiyuan
“Taiyuan Private Hospitals Price Integrity Evaluation Index System (Revised Draft)” Officially Released to the Public. The number of veto criteria in the new standard has increased from three last year to eight, with additional regulatory content closely linked to price integrity construction added from departments such as Industry and Commerce, Food and Drug Administration, and Human Resources and Social Security.
Dongguan Releases Implementation Plan for Comprehensive Reform of Public Hospitals, Establishes Electronic Health Records for Residents
The Dongguan Municipal Health and Family Planning Commission has publicly released the "Implementation Plan for the Comprehensive Reform of Urban Public Hospitals in Dongguan," which is regarded as the "roadmap" for deepening healthcare reform in Dongguan. The Plan clearly states that by the end of 2017, the profit-driven mechanism of public hospitals will be basically eliminated, unreasonable growth in medical and pharmaceutical expenses will be effectively controlled, and "the proportion of out-of-pocket personal health expenditure to total health expenditure will generally be reduced to below 30%." A novel aspect of this plan is the introduction of a trial "annual salary system for hospital presidents" in Dongguan's public hospitals, for which the "Guiding Opinions on Compensation Distribution in Dongguan Public Hospitals" have already been issued.
————————————Data————————————
China’s Online Healthcare Market Size Expected to Exceed RMB 17 Billion This Year
Recently, iResearch released the "2015 China Online Healthcare Industry Research Report." Statistical data show that the market size of online healthcare in 2014 was RMB 10.88 billion. The market has been expanding rapidly, demonstrating a trend of sustained high growth, and is projected to exceed RMB 17 billion in 2015.
Accenture Report: Internet Healthcare Saves the U.S. $10 Billion Annually
Accenture’s latest research findings indicate that the use of internet-based healthcare tools in primary care could save the U.S. healthcare system $10 billion annually.
By 2025, the United States is projected to face a shortage of nearly 31,000 primary care physicians. Meanwhile, the populations of elderly patients and those with chronic diseases continue to grow. Consequently, the adoption of digital health solutions will enable physicians to save time and treat more patients. Accenture has identified three areas with the potential to improve care delivery and optimize workflows: annual patient physical examinations, continuous patient management, and patient self-care.
The National Working Commission on Aging predicts that China will enter a phase of rapid population aging.
The National Working Commission on Ageing predicts that from 2015 to 2035, China will enter a phase of rapid aging, with the elderly population increasing from 212 million to 418 million, accounting for 29% of the total population. Currently, the rate of empty-nest elderly households in China has reached 50%, reaching 70% in large and medium-sized cities, placing immense pressure on elderly care.
Meanwhile, the Beijing Municipal Civil Affairs Bureau recently announced that the “Service Guidelines for Elderly Care Institutions in the Beijing-Tianjin-Hebei Region” will soon be issued. Under these guidelines, residents will be free to choose nursing homes across the three regions, with various subsidies provided by their household registration (hukou) authorities following them to their chosen facilities. For instance, elderly residents from Beijing will be able to reside in nursing homes located in Zhangjiakou, Laishui, Chengde, Wuqing, and other areas.
UN Report: China's R&D Spending Rises to Second Globally
A report released by UNESCO on the 10th shows that despite the impact of the global financial crisis that erupted in 2008 on the economies of developed countries, total global R&D expenditure still rose from $1.132 trillion to $1.478 trillion between 2007 and 2013, an increase of 31%, exceeding the growth rate of global GDP during the same period.
In terms of the geographic distribution of R&D investment, the United States accounts for 28% of global R&D expenditure; China ranks second with 20%; the European Union and Japan follow with 19% and 10%, respectively. The remaining 23% of R&D spending comes from other countries, which account for approximately 67% of the world’s total population.
Mobile Healthcare Market Poised for Growth: Total Scale to Exceed 8 Trillion Yuan by 2020
Recently, the “Series of Research Reports on the Medical and Health Industry” released by CCID Consulting proposed that, against the backdrop of a large population, accelerating aging, technological breakthroughs, the “Internet Plus” initiative, and healthcare system reforms, China’s medical and health industry is ushering in rapid development opportunities. It is projected that by 2020, the total scale of China’s medical and health industry will exceed RMB 8 trillion.
CCID Consulting believes that the era of “Internet Plus” has arrived. Pharmaceutical e-commerce and mobile healthcare have become typical representatives of the integration between the internet and the healthcare industry, representing the future direction of industrial development. They are not only key areas strongly supported by national policies but also hotspots for current capital market investment. While providing convenient services to the public, pharmaceutical e-commerce and mobile healthcare also bring new development opportunities to the traditional healthcare industry, with promising market prospects.
1,276 Deaths from Statutorily Notifiable Infectious Diseases in October
The National Health and Family Planning Commission website released the announcement on the epidemic situation of notifiable infectious diseases nationwide in October. The announcement showed that a total of 542,178 cases of notifiable infectious diseases were reported nationwide (excluding Hong Kong, Macao, and Taiwan) in October, with 1,276 deaths. Among them, there were no reported cases or deaths of plague, a Class A infectious disease; two cases of cholera were reported, with no deaths.
The announcement indicated that among Class B infectious diseases, there were no reported cases or deaths of severe acute respiratory syndrome (SARS), poliomyelitis, diphtheria, or human infection with highly pathogenic avian influenza. The remaining 22 Class B infectious diseases collectively accounted for 280,296 reported cases and 1,268 deaths. The top five diseases by number of reported cases were viral hepatitis, tuberculosis, syphilis, bacterial and amoebic dysentery, and schistosomiasis, which together comprised 91% of the total reported cases of Class B infectious diseases.
During the same period, a total of 261,880 cases and 8 deaths from Class C notifiable infectious diseases were reported nationwide. Among these, no cases or deaths of filariasis were reported. The top three diseases by number of reported cases were hand, foot and mouth disease, other infectious diarrheal diseases, and epidemic parotitis (mumps), accounting for 95% of the total reported cases of Class C notifiable infectious diseases.
Prediction: The Cell Detection Market Will Be Worth $18.3 Billion by 2020
According to estimates by IMS Institute for Healthcare Informatics, the global cell assay market is expected to grow from approximately $10.8 billion in 2015 to $18.3 billion in 2020, representing a compound annual growth rate (CAGR) of 11.16% between 2015 and 2020. Factors driving the growth of the cell assay market include increased research and development expenditures, the expanding use of cell assays in drug screening, and advances in automation and high-throughput technologies.
————————New Technologies————————
Band-Aid-Style Thermometer: Measure Temperature with a Single Patch
Japanese-U.S. Research Team Announces Development of Thin, Soft, Flexible Film-Like Thermometer
Takao Someya, a professor of electronic engineering at the University of Tokyo, stated, “By adhering to the skin like a bandage, it enables continuous and gentle monitoring of infants, wounds, and other conditions.”
The research team fabricated circuits that function as temperature sensors using a special resin on plastic sheets 0.015 mm thick. Upon contact with the skin, the resin expands slightly in response to body temperature, and the resulting changes in the circuit’s electrical resistance are converted into temperature readings.
WiFi Signal Wall-Penetration Observation: Can See Through Clothes to Measure Human Pulse
Scientists at the Massachusetts Institute of Technology have developed a technology that uses Wi-Fi signals to observe through walls, capable of identifying individuals behind walls with 90% accuracy, while researchers in the United Kingdom have achieved the ability to discern human body contours through clothing.
According to reports, this technology not only enables scientists to visualize the silhouettes of experimental participants in adjacent rooms but also calculates their pulse and respiration rates. Known as the RF-Capture system, the technology operates by transmitting Wi-Fi signals through obstacles. When detecting human bodies beyond the line of sight, the RF-Capture system analyzes the return paths of the signals. The resulting data is then used to generate images.
Scientists believe that this new research invention elevates the care of isolated patients to a new level. For example, the RF-Capture system can autonomously analyze a patient’s movements within a room; if the patient falls or shows no vital signs, the system can automatically call for emergency assistance.
Japanese Team Develops Prosthetic Limb Controlled by Electromyographic Signals
A research team led by Professor Hirofumi Yokoi of the University of Electro-Communications in Japan announced that they had successfully developed a prosthetic hand controlled by electrical signals generated during muscle contraction. This prosthetic hand can adjust its grip strength, enabling it to perform relatively complex tasks such as moving a cup filled with water and tying shoelaces with fingers.
Furthermore, according to team members, the most distinctive feature of this prosthetic hand is that users can master its operation after just 1–2 minutes of training and perform over 80% of the movements required for daily living.
A 3D Finger Scanner Addresses Challenges in Early Arthritis Diagnosis, Facilitating Pharmacological Treatment
The EU project IACOBUS, led by the Fraunhofer Institute for Biomedical Engineering in Germany, has developed a finger scanner that addresses the challenge of early diagnosis of arthritis.
3D Finger Scanner: A Substitute for MRI in the Early Diagnosis of Arthritis. The finger scanner utilizes photoacoustic imaging technology. Patients simply insert their fingers into the device, where they are briefly exposed to laser pulses. This causes slight heating and expansion of the finger tissues, allowing the scanner to visualize joint inflammation through images, similar to Doppler ultrasound examinations.
To enable more precise examinations, researchers have also developed a hyperspectral imaging system that illuminates the finger with intense white light. By analyzing the wavelengths of backscattered light—since inflamed tissues absorb specific wavelengths—the progression of arthritis can be assessed. Experts believe that combining ultrasound imaging with hyperspectral imaging systems will fully enable the early diagnosis of arthritis.
Look at this technology—it completely shatters one’s preconceived notions.
————————————Capital————————————